{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:02:37Z","timestamp":1787623357455,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["118S399"],"award-info":[{"award-number":["118S399"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008967","name":"Bilim Akademisi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008967","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jbc.2025.110864","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:02:59Z","timestamp":1761588179000},"page":"110864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Purinergic ecto-enzyme CD73 is a context-dependent tumor suppressor in colorectal cancer"],"prefix":"10.1016","volume":"301","author":[{"given":"Tieu Lan","family":"Chau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7854-7337","authenticated-orcid":false,"given":"\u00dcmran","family":"Borucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0528-9099","authenticated-orcid":false,"given":"Beste","family":"Uygur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-1843","authenticated-orcid":false,"given":"Ahmet G\u00f6ktu\u011f","family":"\u00d6zkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9018-9883","authenticated-orcid":false,"given":"Eyl\u00fcl","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2210-2329","authenticated-orcid":false,"given":"Aynur","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Dila","family":"Gemalmayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caglar","family":"Cekic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytekin","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-7962","authenticated-orcid":false,"given":"Se\u00e7il","family":"Demirkol Canl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-768X","authenticated-orcid":false,"given":"Serkan \u0130smail","family":"G\u00f6ktuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110864_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2025.110864_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2013.07.032","article-title":"Chronic ulcerative colitis and colorectal cancer","volume":"345","author":"Rogler","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2025.110864_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ccell.2020.11.009","article-title":"Immunomodulation by targeted anticancer agents","volume":"39","author":"Petroni","year":"2021","journal-title":"Cancer cell"},{"key":"10.1016\/j.jbc.2025.110864_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/485156","article-title":"CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth","volume":"2012","author":"Allard","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jbc.2025.110864_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2025.110864_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.110864_bib7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","article-title":"CD39\/CD73\/A2AR pathway and cancer immunotherapy","volume":"22","author":"Xia","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.110864_bib8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbc.2025.110864_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4049\/jimmunol.1003884","article-title":"Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production","author":"Clayton","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jbc.2025.110864_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020177","article-title":"CD73, tumor plasticity and immune evasion in solid cancers","volume":"13","author":"Yang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jbc.2025.110864_bib11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00280-020-04077-1","article-title":"CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model","volume":"85","author":"Azambuja","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110864_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","article-title":"Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma","volume":"26","author":"Goswami","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2025.110864_bib13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/14728222.2014.915315","article-title":"Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer","volume":"18","author":"Allard","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jbc.2025.110864_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1172\/JCI79380","article-title":"Loss of CD73-mediated actin polymerization promotes endometrial tumor progression","volume":"126","author":"Bowser","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.110864_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coph.2020.07.001","article-title":"Targeting CD73 to augment cancer immunotherapy","volume":"53","author":"Roh","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110864_bib16","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1007\/s13277-015-3212-x","article-title":"The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jbc.2025.110864_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/carcin\/bgy154","article-title":"Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer","volume":"40","author":"Koivisto","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jbc.2025.110864_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ijc.31112","article-title":"Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT\/GSK-3\u03b2\/\u03b2-catenin\/cyclinD1 signaling pathway","volume":"142","author":"Yu","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2025.110864_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s12253-013-9648-7","article-title":"Overexpression of CD73 in prostate cancer is associated with lymph node metastasis","volume":"19","author":"Yang","year":"2013","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jbc.2025.110864_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1078-0432.CCR-15-1181","article-title":"CD73 expression is an independent prognostic factor in prostate cancer","volume":"22","author":"Leclerc","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110864_bib21","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.18632\/oncotarget.14434","article-title":"Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer","volume":"8","author":"Inoue","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.110864_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.jbc.2025.110864_bib23","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110864_bib24","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1016\/j.febslet.2015.07.027","article-title":"CD73 and CD39 ectonucleotidases in T cell differentiation: beyond immunosuppression","volume":"589","author":"Bono","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbc.2025.110864_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1042\/bj20020439","article-title":"The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells","volume":"367","author":"Yegutkin","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.110864_bib26","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2025.110864_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-017-3291-8","article-title":"MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73","volume":"17","author":"Xie","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2025.110864_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3892\/ol_00000076","article-title":"Reduced CD73 expression and its association with altered purine nucleotide metabolism in colorectal cancer cells robustly causing liver metastases","volume":"1","author":"Matsuyama","year":"2010","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2025.110864_bib29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jso.23159","article-title":"CD73 as a novel prognostic biomarker for human colorectal cancer","volume":"106","author":"Liu","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbc.2025.110864_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103269","article-title":"The prognostic impact of the tumour stroma fraction: a machine learning-based analysis in 16 human solid tumour types","volume":"65","author":"Micke","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2025.110864_bib31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.110864_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1470-2045(22)00324-2","article-title":"Immunotherapy in colorectal cancer: an unmet need deserving of change","volume":"23","author":"Elez","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2025.110864_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41467-019-14060-x","article-title":"CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110864_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.21873\/anticanres.13124","article-title":"Mesenchymal stem cell marker expression in gastric cancer stroma","volume":"39","author":"Numakura","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbc.2025.110864_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphar.2018.00153","article-title":"Unveiling the role of Ecto-5'-Nucleotidase\/CD73 in Astrocyte migration by using pharmacological tools","volume":"9","author":"Adzic","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110864_bib36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3892\/ol.2020.11670","article-title":"CD73 promotes colitis-associated tumorigenesis in mice","volume":"20","author":"Liu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jbc.2025.110864_bib37","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/s41598-021-85379-z","article-title":"CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer","volume":"11","author":"Petruk","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110864_bib38","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1111\/jcmm.15500","article-title":"CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer","volume":"24","author":"Chen","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jbc.2025.110864_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1224963","article-title":"CD73s protection of epithelial integrity: thinking beyond the barrier","volume":"4","author":"Bowser","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jbc.2025.110864_bib40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/eji.201444856","article-title":"Ecto-5'-nucleotidase\/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature","volume":"45","author":"Yegutkin","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jbc.2025.110864_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2021.01.030","article-title":"Loss of CD73 shifts transforming growth factor-\u03b21 (TGF-\u03b21) from tumor suppressor to promoter in endometrial cancer","volume":"505","author":"Kurnit","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2025.110864_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.tcb.2021.05.008","article-title":"The elegant complexity of mammalian ecto-5'-nucleotidase (CD73)","volume":"31","author":"Alcedo","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jbc.2025.110864_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrc3246","article-title":"The determinants of tumour immunogenicity","volume":"12","author":"Blankenstein","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.110864_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166494","article-title":"Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment","author":"Huang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.110864_bib45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2217\/imt-2018-0200","article-title":"CD73: an emerging checkpoint for cancer immunotherapy","volume":"11","author":"Chen","year":"2019","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jbc.2025.110864_bib46","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/0008-5472.CAN-09-3109","article-title":"CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110864_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84508.sa2","article-title":"The CD73 immune checkpoint promotes tumor cell metabolic fitness","author":"Allard","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.jbc.2025.110864_bib48","article-title":"Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression","volume":"3","author":"Seager","year":"2017","journal-title":"Convergent Sci. Phys. Oncol."},{"key":"10.1016\/j.jbc.2025.110864_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fonc.2014.00040","article-title":"In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies","volume":"4","author":"McDermott","year":"2014","journal-title":"Front. Oncol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825027164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825027164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T12:29:52Z","timestamp":1767270592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825027164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0021925825027164"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110864","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purinergic ecto-enzyme CD73 is a context-dependent tumor suppressor in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110864"}}